Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 27, 2021
[ Mon, Sep 27th 2021
] - WOPRAI
[ Mon, Sep 27th 2021
] - WOPRAI
[ Mon, Sep 27th 2021
] - WOPRAI
[ Mon, Sep 27th 2021
] - WOPRAI
[ Mon, Sep 27th 2021
] - WOPRAI
[ Mon, Sep 27th 2021
] - WOPRAI
[ Mon, Sep 27th 2021
] - WOPRAI
[ Mon, Sep 27th 2021
] - WOPRAI
[ Mon, Sep 27th 2021
] - WOPRAI
Sun, September 26, 2021
[ Sun, Sep 26th 2021
] - WOPRAI
Fri, September 24, 2021
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
[ Fri, Sep 24th 2021
] - WOPRAI
Dae Gon Ha Initiated (VERV) at Hold and Held Target at $58 on, Sep 24th, 2021
Dae Gon Ha of Stifel, Initiated "Verve Therapeutics, Inc." (VERV) at Hold and Held Target at $58 on, Sep 24th, 2021.
Dae has made no other calls on VERV in the last 4 months.
There are 4 other peers that have a rating on VERV. Out of the 4 peers that are also analyzing VERV, 1 agrees with Dae's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eric Joseph of "JP Morgan" Initiated at Hold and Held Target at $50 on, Monday, July 12th, 2021
These are the ratings of the 3 analyists that currently disagree with Dae
- Etzer Darout of "Guggenheim" Initiated at Strong Buy and Held Target at $84 on, Monday, July 12th, 2021
- Eun Yang of "Jefferies" Initiated at Strong Buy on, Monday, July 12th, 2021
- Raju Prasad of "William Blair" Initiated at Buy and Held Target at $92 on, Monday, July 12th, 2021
